Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Giuseppe MC Rosano"'
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1294-1304 (2023)
Abstract Aims Iron deficiency is a common finding among patients with heart failure (HF) and is associated with adverse outcomes, including decreased quality of life, increased risk of hospitalization, and decreased survival. Intravenous ferric carbo
Externí odkaz:
https://doaj.org/article/9c503788dd1847b79fbd01eb5d2d8a2e
Publikováno v:
Cardiac Failure Review, Vol 8, Iss , Pp - (2022)
The aging population, higher burden of predisposing conditions and comorbidities along with improvements in therapy all contribute to the growing prevalence of heart failure (HF). Although the majority of trials have not demonstrated age-dependent he
Externí odkaz:
https://doaj.org/article/0bb983f9d755413ca893e04f4fec187f
Publikováno v:
Cardiac Failure Review, Vol 5, Iss 3, Pp 130-132 (2019)
Renin–angiotensin–aldosterone system inhibitors (RAASi) are known to improve outcomes in patients who have heart failure with reduced ejection fraction (HFrEF). To reduce mortality in these patients, RAASi should be uptitrated to the maximally to
Externí odkaz:
https://doaj.org/article/c79eef101b394565888d7685ae8638f1
Autor:
Ovidiu Chioncel, Marianna Adamo, Maria Nikolaou, John Parissis, Alexandre Mebazaa, Mehmet Birhan Yilmaz, Christian Hassager, Brenda Moura, Johann Bauersachs, Veli‐Pekka Harjola, Elena‐Laura Antohi, Tuvia Ben Gal, Sean P. Collins, Vlad Anton Iliescu, Magdy Abdelhamid, Jelena Celutkiene, Stamatis Adamopoulos, Lars H Lund, Mariantonietta Cicoira, Josep Masip, Hadi Skouri, Finn Gustafsson, Amina Rakisheva, Ingo Ahrens, Andrea Mortara, Ewa Jankowska, Abdallah Almaghraby, Kevin Damman, Oscar Miro, Kurt Huber, Arsen Ristic, Loreena Hill, Wilfried Mullens, Alaide Chieffo, Josef Bartunek, Pasquale Paolisso, Antoni Bayes‐Genis, Stefan D Anker, Susanna Price, Gerasimos Filippatos, Frank Ruschitzka, Petar Seferovic, Rafael Vidal Perez, Alec Vahanian, Marco Metra, Theresa A McDonagh, Emanuele Barbato, Andrew JS Coats, Giuseppe MC Rosano
Publikováno v:
European Journal of Heart Failure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07ba0b4c7bf14d5f7007badc0c0cc650
https://doi.org/10.1002/ejhf.2918
https://doi.org/10.1002/ejhf.2918
Autor:
Stefan D. Anker, Muhammad Shariq Usman, Markus S. Anker, Javed Butler, Michael Böhm, William T Abraham, Marianna Adamo, Vijay K Chopra, Mariantonietta Cicoira, Francesco Cosentino, Gerasimos Filippatos, Lars H Lund, Brenda Moura, Wilfried Mullens, Burkert Pieske, Piotr Ponikowski, Jose R. Gonzalez‐Juanatey, Gianluigi Savarese, Petar Seferovic, John R. Teerlink, Carsten Tschöpe, Maurizio Volterrani, Stephan von Haehling, Jian Zhang, Yuhui Zhang, Johann Bauersachs, Ulf Landmesser, Shelley Zieroth, Konstantinos Tsioufis, Antoni Bayes‐Genis, Ovidiu Chioncel, Felicita Andreotti, Enrico Agabiti‐Rosei, Jose L. Merino, Marco Metra, Andrew JS Coats, Giuseppe MC Rosano
Publikováno v:
European Journal of Heart Failure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbf05b34d81513c805fbb95f503c69f9
https://doi.org/10.1002/ejhf.2894
https://doi.org/10.1002/ejhf.2894
Autor:
Marat Fudim, Camilla Hage, B. Schrage, Giuseppe Mc Rosano, Ulf Dahlström, Anna Lundberg, Tonje Thorvaldsen, Lars H. Lund, Cecilia Linde, Gianluigi Savarese, Lina Benson
Publikováno v:
Journal of Internal Medicine
Background Randomized controlled trials (RCT) generalizability may be limited due to strict patient selection. Objective In a real-world heart failure (HF) population, we assessed eligibility for sacubitril/valsartan based on PARADIGM-HF (sacubitril/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e4661172e48a48465b4721942a6f59
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-170065
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-170065
Autor:
Yuri Lopatin, Giuseppe Mc Rosano
Publikováno v:
International Cardiovascular Forum Journal, Vol 10, Pp 37-40 (2017)
The clinical course of heart failure includes a period in which the patient is at increased risk of death or rehospitalisation for HF. This period is termed the “vulnerable phase” and occurs during the peri-acute HF phase, due to microenvironment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d39e3528c7207794ccb92bcc0b04525
http://icfjournal.org/index.php/icfj/article/view/444/444
http://icfjournal.org/index.php/icfj/article/view/444/444
Publikováno v:
Cardiac failure review. 3(1)
Diabetes and heart failure are closely related: patients with diabetes have an increased risk of developing heart failure and those with heart failure are at higher risk of developing diabetes. Furthermore, antidiabetic medications increase the risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe509fd6c0aee29cac2f65559509352
https://pubmed.ncbi.nlm.nih.gov/28785476
https://pubmed.ncbi.nlm.nih.gov/28785476
Publikováno v:
International Cardiovascular Forum Journal, Vol 10, Pp 68-69 (2017)
The 2016 ESC/HFA HF guidelines carry an important section on the treatments of co- morbidities in HF. Foremost of these in terms of frequency and its relevance to the aetiology of HF, especially HFpEF is hypertension. In this artcile we will review w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::915513554979b8fd093b2aafef7fc7db
http://icfjournal.org/index.php/icfj/article/view/452/452
http://icfjournal.org/index.php/icfj/article/view/452/452
Publikováno v:
British Menopause Society Journal. 5:30-35
Coronary heart disease presents clinically as angina pectoris, myocardial infarction, cardiac failure, arrhythmias or sudden death. The menopause adversely affects coronary artery disease progression because of the negative influence of oestrogen def
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f81d0e899df7e6d9578128c8187934a
https://doi.org/10.1177/136218079900500108
https://doi.org/10.1177/136218079900500108